Results 121 to 130 of about 9,325 (207)
Human induced pluripotent stem cell derived cardiomyocytes are a powerful model for cardiogenesis and disease in vitro. Here the authors comprehensively map cardiac differentiation using multiple modalities, including single-cell RNA seq and CyTOF, in ...
Jared M. Churko +16 more
doaj +1 more source
Comparison of CyTOF analysis with cytospin for sputum cell differential [PDF]
Janette Birmingham +5 more
openaire +1 more source
CyTOF analysis of immune characteristics in cSLE: belimumab treatment and refractory cases
Introduction Systemic lupus erythematosus (SLE) is a chronic autoimmune disease affecting multiple organs. Some patients still develop severe refractory SLE despite conventional treatments. Belimumab, a biologic targeting B lymphocyte stimulator (BLyS), shows therapeutic promise in SLE, but its effects on ...
Luo, Ying +8 more
openaire +2 more sources
Understanding neutrophil heterogeneity and its relationship to disease progression has become a recent focus of cancer research. Indeed, several studies have identified neutrophil subpopulations associated with pro- or anti-tumoral functions.
Zhu, Yanfang Peipei +5 more
core +1 more source
Introduction High-parameter cytometric analysis enables discoveries of potential therapeutic targets and informs disease prognoses in translational and clinical research.
Stephen Li +4 more
core +1 more source
CyTOF profiling of bone marrow immune dynamics across myeloma stages
Multiple myeloma (MM) orchestrates a profound disruption of immune balance within the bone marrow (BM) microenvironment, driving disease progression and therapeutic resistance. To better understand these complex immune dynamics, we used high-dimensional mass cytometry (CyTOF) profiling to comprehensively characterize the immune landscape of the BM ...
Dana Cholujova +9 more
openaire +3 more sources
Immune profiling of age and adjuvant-specific activation of human blood mononuclear cells in vitro
Vaccination reduces morbidity and mortality due to infections, but efficacy may be limited due to distinct immunogenicity at the extremes of age. This raises the possibility of employing adjuvants to enhance immunogenicity and protection.
Simone S. Schüller +7 more
doaj +1 more source

